The Wegovy oral pill (oral semaglutide) launched in January 2026, and Foundayo (orforglipron), a new oral GLP-1, was FDA-approved on April 1, 2026
PlexusDx supports precision-informed conversations between patients and providers by contextualizing how individual genetic predispositions in peptide metabolism pathways may influence medication tolerance and symptom response during illness
Statistics show that individuals using this type of solution report a noticeable improvement in quality of life, greater self-confidence, and better health-check results
Drug Des Devel Ther 13:29852996 Aohua Wang TY, Fan W, Yang Y, Zhu Q, Guo S, Zhu C, Yuan Y, Zhang T, Gan Y (2018) Protein corona liposomes achieve efficient oral insulin delivery by overcoming mucus and epithelial barriers
Eating Leftovers Out of Guilt Eating leftovers after feeling full due to guilt is another cause of excessive weight